RA Capital Management as of March 31, 2013
Portfolio Holdings for RA Capital Management
RA Capital Management holds 21 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 19.9 | $86M | 11M | 7.94 | |
| Sangamo Biosciences (SGMO) | 12.8 | $56M | 5.8M | 9.56 | |
| Keryx Biopharmaceuticals | 9.2 | $40M | 5.6M | 7.04 | |
| Dyax | 8.6 | $37M | 8.5M | 4.36 | |
| Achillion Pharmaceuticals | 6.4 | $28M | 3.2M | 8.75 | |
| Hyperion Therapeutics | 6.4 | $28M | 1.1M | 25.82 | |
| Sunesis Pharmaceuticals | 6.2 | $27M | 4.9M | 5.47 | |
| XOMA CORP Common equity shares | 5.4 | $23M | 6.7M | 3.49 | |
| Newlink Genetics Corporation | 4.5 | $19M | 1.6M | 12.27 | |
| Derma Sciences | 4.4 | $19M | 1.6M | 12.08 | |
| Insmed (INSM) | 4.2 | $18M | 2.4M | 7.49 | |
| Sequenom | 3.4 | $15M | 3.5M | 4.15 | |
| ArthroCare Corporation | 3.1 | $14M | 388k | 34.76 | |
| OncoGenex Pharmaceuticals | 2.3 | $9.8M | 863k | 11.33 | |
| D Stemline Therapeutics | 1.0 | $4.5M | 394k | 11.41 | |
| Mei Pharma | 0.8 | $3.2M | 375k | 8.63 | |
| Senomyx | 0.7 | $3.2M | 1.5M | 2.11 | |
| Immunomedics | 0.6 | $2.4M | 1.0M | 2.41 | |
| ZIOPHARM Oncology | 0.1 | $404k | 221k | 1.83 | |
| Savient Pharmaceuticals note | 0.1 | $270k | 1.0M | 0.27 | |
| Novavax | 0.1 | $228k | 100k | 2.28 |
